Shaheer Mannan M.D.

Aspiring Oncologist 🦀 || IM Resident 🩺 || Alumni @cmhlmc @CCHAlumni || Performing Arts 🎭 || Tennis 🎾 || Swimming 🏊‍♀️|| 🇺🇲 🇵🇰

[OncoDaily @oncodaily]

MRD-Guided Maintenance Therapy in Newly Diagnosed Multiple Myeloma - @shaheermannan

https://t.co/Ty1VLO5AIl

[Shaheer Mannan M.D. @shaheermannan]

Grateful to all my mentors, humbled by the opportunity! ASCO 26

https://t.co/srKMZP42U9

[Shaheer Mannan M.D. @shaheermannan]

Really grateful to all involved! Truly a team effort!

https://t.co/SOcJQq47Cf

[Shaheer Mannan M.D. @shaheermannan]

So excited for this!

https://t.co/rnp7OeegHj

[Shaheer Mannan M.D. @shaheermannan]

Excited to share that 2 of our CAR-T research abstracts have been accepted at the Society for Immunotherapy of Cancer (SITC) as First Author.

CAR-T therapy represents one of the most transformative breakthroughs in modern oncology!

https://t.co/qPNV9fTrG6

[Shaheer Mannan M.D. @shaheermannan]

https://t.co/2hhuW4CHyI

[Shaheer Mannan M.D. @shaheermannan]

Enjoyed presenting our work on EGFR inhibitor therapy in anal squamous cell carcinoma (ASCC) at GI ASCO 2026.
#GIASCO2026 #ASCO #OncologyResearch

https://t.co/zpMQsw1g8r

[Shaheer Mannan M.D. @shaheermannan]

Conference season in full swing.
Grateful to present and engage in impactful discussions at major oncology & hematology meetings.

Looking forward to advancing research that translates into better patient care.

https://t.co/VhOa50Ffho

[Shaheer Mannan M.D. @shaheermannan]

Honored and humbled to celebrate another step forward in my growth as an aspiring oncologist. Grateful for the mentors and colleagues who continue to guide this journey. Details below 👇 https://t.co/tq2j09FFhZ

[Shaheer Mannan M.D. @shaheermannan]

Sharing my recent Journal Club Presentation for 2025, where I discussed the ANNEXA-I NEJM trial on andexanet in DOAC-associated intracerebral hemorrhage — quick takeaways on hemostasis, outcomes, and safety. Posting the full details below 👇

https://t.co/VXlC4Jxj6C

[Shaheer Mannan M.D. @shaheermannan]

Humbled to be part of such an impactful project! Thanks to great mentor @mshahzadmd

[Moazzam Shahzad, MD @mshahzadmd]

Our latest articles in @tandfonline expolers the efficacy and safety of #Imetelstat in relapsed, #JAKI refractory #myelofibrosis patients. @MoffittNews @mumairmushtaq #research #leukemiaandlymphoma #myeloproliferativeneoplasms
https://t.co/B6Y0CejJY2

[Shaheer Mannan M.D. @shaheermannan]

@AhmedNadeemMD @CCF_IMCHIEFS @CCF_GIFellows @AKUGlobal Congratulations! You have always been a true role model of excellence and inspiration to many! ✨️

[Shaheer Mannan M.D. @shaheermannan]

Honored to have 10 of our #ASH25 abstract accepted! Grateful to my mentor @mshahzadmd and my institution @SanfordHealth- @mfldclinic for guidance. Excited to discuss implications for real-world care. 🚀🩸

#ASH25, #ASH2025, #MedTwitter, #HemeOnc

https://t.co/SFOQdd8y0S

[Abhishek Kataria @ak_abhi_md]

Excited to share our case report, published recently:

AA amyloidosis with multiorgan involvement secondary to familial Mediterranean fever (FMF): dreadful consequences of delayed diagnosis and management

https://t.co/xaGWZqLAVL

[Shaheer Mannan M.D. @shaheermannan]

https://t.co/59qZMbU44s

[Shaheer Mannan M.D. @shaheermannan]

https://t.co/IxdOJDLYia

[Shaheer Mannan M.D. @shaheermannan]

https://t.co/CIT4K5F3Zz

[Shaheer Mannan M.D. @shaheermannan]

https://t.co/BCf3i9Su6B

[Faiz Anwer MD @FaizAnwerMD1]

A rare case of Amyloidosis.

AA amyloidosis with multiorgan involvement secondary to familial Mediterranean fever (FMF): dreadful consequences of delayed diagnosis and management

https://t.co/JgvKm0p8gJ

[Shaheer Mannan M.D. @shaheermannan]

@FaizAnwerMD1 @khouri_jack @LouisWilliamsMD @Bethfaiman @zainab_mot @Hamza_HassanMD Wonderful work! A very pertinent and important topic tackled very well!